Muñoz-Vendrell, A., Campoy-Díaz, S., Valín-Villanueva, P., Casas-Limón, J., Fernández-Lázaro, I., González-García, N., . . . Huerta-Villanueva, M. (2025). Atogepant after anti-CGRP monoclonal antibodies failure in migraine: A multicenter real-world study of effectiveness, safety, persistence and predictors of response.
Citación estilo ChicagoMuñoz-Vendrell, Albert, et al. Atogepant After Anti-CGRP Monoclonal Antibodies Failure in Migraine: A Multicenter Real-world Study of Effectiveness, Safety, Persistence and Predictors of Response. 2025.
Cita MLAMuñoz-Vendrell, Albert, et al. Atogepant After Anti-CGRP Monoclonal Antibodies Failure in Migraine: A Multicenter Real-world Study of Effectiveness, Safety, Persistence and Predictors of Response. 2025.